However, emphasis should remain on evidence-based dietary patterns such as those recommended by NICE and Diabetes UK, which prioritise whole foods, fibre, and balanced macronutrient distribution
The researchers did not analyze whether patients had a prior history of gout, which could also influence risk
Benefits and harms of once-weekly glucagon-like peptide-1 receptor agonist treatments a systematic review and network meta-analysis comparative clinical profiles of once-weekly GLP-1RAs
(see below) Severe and ongoing symptoms of nausea, vomiting, diarrhea, constipation or other gastrointestinal issues that are treated with emergency room visits, hospitalizations, multiple physician visits
Your healthcare team can provide a structured plan for safely transitioning to alternative therapies if GLP-1 treatment is no longer appropriate, including adjustments to any insulin or sulfonylurea doses to prevent hypoglycaemia
Pearls and Quotes GLP-1 Agonists: Mechanisms to Applications The selection and dosing of GLP-1 and GIP agonists (GLP-1s and GIPs) depends on their intended use as an anti-glycemic or anti-obesity agent
.png)
